Skip to content

High Intensity Body-weight Circuit Training Feasibility and Efficacy for in Middle Aged Persons With Type 2 Diabetes

High Intensity Body-weight Circuit Training Feasibility and Efficacy for Improving Metabolic Profile, Body Composition, and Health-Related Fitness in Middle Aged Persons With Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05571384
Enrollment
22
Registered
2022-10-07
Start date
2022-07-26
Completion date
2025-07-31
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2diabetes

Keywords

Exercise

Brief summary

This research study proposes to quantify the efficacy of the novel high intensity body-weight circuit (HIBC) training intervention on metabolic profile, body composition, and health related fitness exercise in middle aged persons with type-2 diabetes (T2DM). This research project is extremely relevant to public health, in that prevalence of T2DM continues to rise on a national and global scale, placing a heavy economic cost on both the healthcare industry and the individual patient in an age-dependent fashion. Results of this study may provide an effective and appealing alternative exercise intervention for cardiometabolic disease management in adults with T2DM, and have significant clinical and public health applications.

Interventions

BEHAVIORALhigh intensity body-weight circuit

Bodyweight and suspension training equipment (TRX® Fit System) with modified movements. Modified Squats: participants will be instructed to hold the handles of the band with arms extended, participants will then lean back in a standing position and perform a squat within a comfortable range of motion while weight is being distributed to the band. Modified Rows: participants will grab the bands with arms and legs extended. They will find a comfortable angle by which to perform a row (pulling the handles to the rib cage) with arms at a 45-degree angle. Modified Push-Ups: perform push-ups on their knees with a flat back and hands underneath their shoulders. They will be instructed to lower their chest towards the ground in a controlled manner and as far as comfort will allow them. Modified Crunches: participants will lay on their back with feet approximately 8-10 inches from their buttocks, and asked to lift their shoulders slightly off the ground.

Sponsors

Kennesaw State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Recent diagnosed of type 2 diabetes (T2DM) (within a year) \* HbA1c of 6% or higher * Non-insulin dependent * No medicinal treatment * Not currently undergoing a physical activity program in the last six months * Received written medical clearance from overseeing physician

Exclusion criteria

* Those who have undergone any revascularization procedure * Diagnosed with or symptomatic of any renal, pulmonary, or cardiovascular disease (CVD) * Diagnosed cognitive dysfunction * Current smoker

Design outcomes

Primary

MeasureTime frameDescription
HbA1c change within participantPre and post 16-week interventionHbA1c (glycosylated Hemoglobin) indicates what the blood glucose environment was like for that past 3-months. This is the average life span of a red blood cell. High levels of blood glucose over a 3 month period lead to high HbA1c and vis versa. HbA1c can change as early as 14 weeks.
Oral Glucose Tolerance Test change within participantPre and post 16-week interventionGlucose and Insulin response to bolus amount of glucose beverage
Body Composition change within participantPre and post 16-week interventionFat mass and lean mass
Estimated VO2max (oxygen consumption), aerobic exercise capacity change within participantPre and post 16-week interventionsub maximal treadmill endurance test

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026